Radiation-associated angiosarcoma of the breast: consider chemotherapy.

Date publication

juin 2025

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr RIOS Maria

Tous les auteurs :
Michot A, Giraud A, Karanian M, Laé M, Fau M, Adam D, Wernert R, Valentin T, Guilloit JM, Calais G, Rios M, Le Cesne A, Thyss A, Causeret S, Italiano A, Sunyach MP, Tzanis D, Blay JY, Sargos P, Bonvalot S, Le Loarer F, Stoeckle E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40753683

Résumé

Radiation-associated angiosarcoma (RAAS) of the breast arises as a rare secondary effect of radiotherapy administered for breast cancer. The prognosis for RAAS is poorly understood, and surgical outcomes are often unsatisfactory. Our group investigated the impact of neoadjuvant chemotherapy (NAC) on RAAS. This study aims to refine prognostic factors and assess the effect of NAC on breast RAAS.

Référence

Eur J Surg Oncol. 2025 06 19;51(9):110202